Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/1273
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles
Peer Review Status: Refereed
Title: Complementary and alternative medicine use in patients with haematological malignancies in Europe
Author(s): Molassiotis, Alexander
Margulies, Anita
Fernandez-Ortega, Paz
Pud, Dorit
Panteli, Vassiliki
Bruyns, Ingrid
Scott, Julia
Gudmundsdottir, Gudbjorg
Browall, Maria
Madsen, Elin
Ozden, Gulten
Magri, Miriam
Selvekerova, Sarka
Platin, Nurgun
Kearney, Nora
Patiraki, Elisabeth
Contact Email: nora.kearney@stir.ac.uk
Keywords: Haematologic cancers
myeloma
lymphoma
Cancer Alternative treatment
Alternative Medicine methods
Blood cells Examination
Oncology
Issue Date: May-2005
Date Deposited: 2-Jun-2009
Citation: Molassiotis A, Margulies A, Fernandez-Ortega P, Pud D, Panteli V, Bruyns I, Scott J, Gudmundsdottir G, Browall M, Madsen E, Ozden G, Magri M, Selvekerova S, Platin N, Kearney N & Patiraki E (2005) Complementary and alternative medicine use in patients with haematological malignancies in Europe. Complementary Therapies in Clinical Practice, 11 (2), pp. 105-110. https://doi.org/10.1016/j.ctcp.2004.12.005
Abstract: Summary This study reports upon a descriptive cross-sectional survey assessing the use of complementary and alternative medicine (CAM) in patients with haematological cancers. Twelve European countries contributed data from patients with haematological cancers, as part of a larger study. Sixty-eight patients with haematological cancer participated. Among the participants, 26.5% used some form of CAM after the cancer diagnosis. The most common therapies used were homeopathy (38.9%), herbal medicine (22.2%) various psychic therapies, such as use of mediums, healers, rebirthing or past life regression therapy (22.2%). A particular profile of a CAM user was not evident in the sample. Moderate levels of satisfaction with CAM were reported. Patients commonly used CAM to increase the ability of their body to fight cancer and to improve physical and emotional wellbeing. Information about CAM was received mainly from friends or family. As CAM use in patients with haematological malignancies is common, clinicians should assist patients who want to use CAM to make an appropriate decision, and improve communication with them about CAM use in an open and non-judgemental dialogue.
DOI Link: 10.1016/j.ctcp.2004.12.005
Rights: The publisher does not allow this work to be made publicly available in this Repository. Please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author; you can only request a copy if you wish to use this work for your own research or private study.
Licence URL(s): http://www.rioxx.net/licenses/under-embargo-all-rights-reserved

Files in This Item:
File Description SizeFormat 
Molassiotis - Complementary and alternative medicine use in patients with haematological malignancies in Europe.pdfFulltext - Published Version178.88 kBAdobe PDFUnder Embargo until 3000-01-01    Request a copy

Note: If any of the files in this item are currently embargoed, you can request a copy directly from the author by clicking the padlock icon above. However, this facility is dependent on the depositor still being contactable at their original email address.



This item is protected by original copyright



Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.